Fusionproteins in tumors with low mutational burden represent functional neoantigens that elicit Tcell activation and mediate responses to immunotherapy httpgo.nature.com2W1kM46Â sloanketteringpic.twitter.comrcbdvOCl54

Fusion-proteins in tumors with low mutational burden represent functional #neoantigens that elicit #Tcell activation and mediate responses to #immunotherapy | http://go.nature.com/2W1kM46  @sloan_ketteringpic.twitter.com/rcbdvOCl54

10:30 EDT 25 Apr 2019 | Nature Publishing

Fusion-proteins in tumors with low mutational burden represent functional #neoantigens that elicit #Tcell activation and mediate responses to #immunotherapy | http://go.nature.com/2W1kM46  @sloan_kettering pic.twitter.com/rcbdvOCl54

More From BioPortfolio on "Fusion-proteins in tumors with low mutational burden represent functional #neoantigens that elicit #Tcell activation and mediate responses to #immunotherapy | http://go.nature.com/2W1kM46  @sloan_ketteringpic.twitter.com/rcbdvOCl54"